Trial Profile
A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 20 May 2020
Price :
$35
*
At a glance
- Drugs Sodium thiosulfate (Primary)
- Indications Calciphylaxis
- Focus Registrational; Therapeutic Use
- Acronyms CALISTA
- Sponsors Hope Pharmaceuticals
- 15 May 2020 Status changed from recruiting to discontinued.
- 25 Aug 2019 Planned End Date changed from 24 May 2020 to 24 May 2021.
- 25 Aug 2019 Planned primary completion date changed from 24 May 2020 to 24 May 2021.